Showing BioInteractions for Arbaclofen Placarbil (DB08892)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Arbaclofen Placarbil is a Gamma-aminobutyric acid type B receptor subunit 1 agonist | ||
1 | Gamma-aminobutyric acid type B receptor subunit 1 agonists | Arbaclofen, Baclofen, Progabide, Taurine |
Interacting Group | Interacting Drugs | |
---|---|---|
Arbaclofen Placarbil is a Gamma-aminobutyric acid type B receptor subunit 2 agonist | ||
1 | Gamma-aminobutyric acid type B receptor subunit 2 agonists | Arbaclofen, Baclofen |
Interacting Group | Interacting Drugs | |
---|---|---|
Arbaclofen Placarbil is a Monocarboxylate transporter 1 substrate | ||
1 | Monocarboxylate transporter 1 inhibitors | Acetoacetic acid, alpha-D-quinovopyranose, alpha-Ketoisovalerate, D-Lactic acid, gamma-Hydroxybutyric acid, Lactic acid, Niflumic acid, Probenecid, Pyruvic acid, Quercetin |
2 | Monocarboxylate transporter 1 substrates | Acetic acid, Acetoacetic acid, Aminohippuric acid, D-Lactic acid, Foscarnet, Glutamic acid, Lactic acid, Methotrexate, Nateglinide, Niacin, Pravastatin, Pyruvic acid, Salicylic acid, Taurocholic acid, Valproic acid |
3 | Monocarboxylate transporter 1 antagonists | Mersalyl |